Proposed Wolbachia-Infected Aedes aegypti Males Biological Pesticide

EPA is seeking public comments on a proposed registration of a biological pesticide containing Wolbachia-infected Aedes aegypti males. The product would be used for mosquito control to reduce populations of Aedes aegypti, which vector diseases such as dengue, Zika, and chikungunya. The Wolbachia bacteria cause reproductive incompatibility when infected males mate with wild-type females, leading to population suppression over time.

Regulated entities and stakeholders should prepare and submit substantive public comments by April 17. Manufacturers of biological pesticides or mosquito control products should review the proposal to determine applicability to their product lines. Parties with expertise in biological control, mosquito ecology, or public health should consider commenting on the efficacy data, environmental safety assessments, and proposed label conditions.